speb/financial-data huggingface dataset:
ACGLN balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 19469000000.00
ACGLN income_statement (annual, 2024-12-31) — Normalized Income: 4312000000.00
ACGLN cash_flow (annual, 2024-12-31) — Operating Cash Flow: 6673000000.00
ACGLN cash_flow (annual, 2024-12-31) — Operating Gains Losses: -673000000.00
ACGLN income_statement (annual, 2024-12-31) — Operating Revenue: 16930000000.00
ACGLN balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 376400000.00
ACGLN balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: -720000000.00
ACGLN balance_sheet (quarterly, 2024-12-31) — Other Equity Adjustments: -720000000.00
ACGLN income_statement (annual, 2024-12-31) — Other Income Expense: 68000000.00
ACGLN balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 780000000.00
ACGLN balance_sheet (quarterly, 2024-12-31) — Other Intangible Assets: 780000000.00
ACGLN income_statement (annual, 2024-12-31) — Other Operating Expenses: 1667000000.00
ACGLN balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 8329000000.00
ACGLN balance_sheet (annual, 2024-12-31) — Payables: 4302000000.00
ACGLN balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 4302000000.00
ACGLN income_statement (annual, 2024-12-31) — Policyholder Benefits Ceded: 3471000000.00
ACGLN income_statement (annual, 2024-12-31) — Policyholder Benefits Gross: 11813000000.00
ACGLN balance_sheet (annual, 2024-12-31) — Preferred Shares Number: 830000.00
ACGLN balance_sheet (annual, 2024-12-31) — Preferred Stock: 830000000.00
ACGLN cash_flow (annual, 2024-12-31) — Preferred Stock Dividend Paid: -40000000.00
ACGLN income_statement (annual, 2024-12-31) — Preferred Stock Dividends: 40000000.00
ACGLN balance_sheet (annual, 2024-12-31) — Preferred Stock Equity: 830000000.00
ACGLN balance_sheet (annual, 2024-12-31) — Prepaid Assets: 2428000000.00
ACGLN income_statement (annual, 2024-12-31) — Pretax Income: 4474000000.00
ACGLN cash_flow (annual, 2024-12-31) — Purchase Of Investment: -36472000000.00
ACGLN cash_flow (annual, 2024-12-31) — Purchase Of PPE: -51000000.00
ACGLN balance_sheet (annual, 2024-12-31) — Receivables: 16055000000.00
ACGLN income_statement (annual, 2024-12-31) — Reconciled Depreciation: 235000000.00
ACGLN cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: -24000000.00
ACGLN balance_sheet (annual, 2024-12-31) — Retained Earnings: 22686000000.00
ACGLN cash_flow (annual, 2024-12-31) — Sale Of Business: 852000000.00
ACGLN cash_flow (annual, 2024-12-31) — Sale Of Investment: 31240000000.00
ACGLN balance_sheet (annual, 2024-12-31) — Share Issued: 595600000.00
ACGLN cash_flow (annual, 2024-12-31) — Stock Based Compensation: 133000000.00
ACGLN balance_sheet (annual, 2024-12-31) — Stockholders Equity: 20820000000.00
ACGLN balance_sheet (annual, 2024-12-31) — Tangible Book Value: 18639000000.00
ACGLN income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
ACGLN income_statement (annual, 2024-12-31) — Tax Provision: 362000000.00
ACGLN income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.08
ACGLN balance_sheet (annual, 2024-12-31) — Total Assets: 70906000000.00
ACGLN balance_sheet (annual, 2024-12-31) — Total Capitalization: 23548000000.00
ACGLN balance_sheet (annual, 2024-12-31) — Total Debt: 2728000000.00
ACGLN balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 20820000000.00
ACGLN income_statement (annual, 2024-12-31) — Total Expenses: 12456000000.00
ACGLN balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 50086000000.00
ACGLN balance_sheet (annual, 2024-12-31) — Treasury Shares Number: 219200000.00
ACGLN balance_sheet (annual, 2024-12-31) — Treasury Stock: 4487000000.00
ACGLN income_statement (quarterly, 2025-03-31) — +Total Revenue: 4592000000.00
ACGLN balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 4879000000.00
ACGLN balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 17788000000.00
ACGLN balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 2588000000.00
ACGLN income_statement (quarterly, 2025-03-31) — Amortization: 49000000.00
ACGLN cash_flow (quarterly, 2025-03-31) — Amortization Cash Flow: 49000000.00
ACGLN cash_flow (quarterly, 2025-03-31) — Amortization Of Intangibles: 49000000.00
ACGLN cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 1760000000.00
ACGLN cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -9000000.00
ACGLN balance_sheet (quarterly, 2025-03-31) — Capital Stock: 831000000.00
ACGLN balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 1187000000.00
ACGLN balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 10034000000.00
ACGLN cash_flow (quarterly, 2025-03-31) — Cash Dividends Paid: -15000000.00
ACGLN cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -241000000.00
ACGLN cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -1008000000.00
ACGLN cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: 1458000000.00
ACGLN cash_flow (quarterly, 2025-03-31) — Change In Account Payable: 504000000.00
ACGLN cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: 78000000.00
ACGLN cash_flow (quarterly, 2025-03-31) — Change In Payable: 504000000.00
ACGLN cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: 504000000.00
ACGLN cash_flow (quarterly, 2025-03-31) — Change In Receivables: -942000000.00
ACGLN cash_flow (quarterly, 2025-03-31) — Change In Working Capital: 779000000.00
ACGLN cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: -942000000.00
ACGLN cash_flow (quarterly, 2025-03-31) — Changes In Cash: 209000000.00
ACGLN balance_sheet (quarterly, 2025-03-31) — Common Stock: 1000000.00
ACGLN cash_flow (quarterly, 2025-03-31) — Common Stock Dividend Paid: -5000000.00
ACGLN balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 20715000000.00
ACGLN cash_flow (quarterly, 2025-03-31) — Common Stock Payments: -224000000.00
ACGLN cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 49000000.00
ACGLN income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 49000000.00
ACGLN income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 564000000.00
ACGLN income_statement (quarterly, 2025-03-31) — EBIT: 713000000.00
ACGLN income_statement (quarterly, 2025-03-31) — Earnings From Equity Interest Net Of Tax: 17000000.00
ACGLN cash_flow (quarterly, 2025-03-31) — Earnings Losses From Equity Investments: -12000000.00
ACGLN cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: 16000000.00
ACGLN cash_flow (quarterly, 2025-03-31) — End Cash Position: 1985000000.00
ACGLN cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -241000000.00
ACGLN cash_flow (quarterly, 2025-03-31) — Free Cash Flow: 1449000000.00
ACGLN cash_flow (quarterly, 2025-03-31) — Gain Loss On Investment Securities: -6000000.00
ACGLN balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: -408000000.00
ACGLN balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 1308000000.00
ACGLN cash_flow (quarterly, 2025-03-31) — Income Tax Paid Supplemental Data: 18000000.00
ACGLN income_statement (quarterly, 2025-03-31) — Interest Expense: 35000000.00
ACGLN income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 35000000.00
ACGLN income_statement (quarterly, 2025-03-31) — Interest Income: 11000000.00
ACGLN cash_flow (quarterly, 2025-03-31) — Interest Paid Supplemental Data: 0.00
ACGLN balance_sheet (quarterly, 2025-03-31) — Invested Capital: 23443000000.00
ACGLN cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -1008000000.00
ACGLN balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 41560000000.00
ACGLN balance_sheet (quarterly, 2025-03-31) — Investments In Other Ventures Under Equity Method: 7645000000.00
ACGLN balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 2728000000.00
ACGLN balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 2728000000.00
ACGLN balance_sheet (quarterly, 2025-03-31) — Long Term Equity Investment: 7645000000.00
ACGLN income_statement (quarterly, 2025-03-31) — Loss Adjustment Expense: 2587000000.00
ACGLN cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: -224000000.00
ACGLN balance_sheet (quarterly, 2025-03-31) — Net Debt: 1541000000.00
ACGLN income_statement (quarterly, 2025-03-31) — Net Income: 574000000.00
ACGLN income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 564000000.00
ACGLN income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 574000000.00
ACGLN income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 574000000.00
ACGLN income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 574000000.00
ACGLN cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 574000000.00
ACGLN income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 574000000.00
ACGLN income_statement (quarterly, 2025-03-31) — Net Interest Income: -35000000.00
ACGLN cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: -997000000.00
ACGLN income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -35000000.00
ACGLN cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -2000000.00
ACGLN cash_flow (quarterly, 2025-03-31) — Net Other Investing Changes: -2000000.00
ACGLN cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -9000000.00
ACGLN income_statement (quarterly, 2025-03-31) — Net Policyholder Benefits And Claims: 2587000000.00
ACGLN balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 20237000000.00
ACGLN income_statement (quarterly, 2025-03-31) — Normalized Income: 574000000.00
ACGLN cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 1458000000.00
ACGLN cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: -18000000.00
ACGLN income_statement (quarterly, 2025-03-31) — Operating Revenue: 4592000000.00
ACGLN balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 375600000.00
ACGLN balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: -408000000.00
ACGLN income_statement (quarterly, 2025-03-31) — Other Income Expense: 51000000.00
ACGLN income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 532000000.00
ACGLN balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 8847000000.00
ACGLN balance_sheet (quarterly, 2025-03-31) — Payables: 4879000000.00
ACGLN balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 4879000000.00
ACGLN income_statement (quarterly, 2025-03-31) — Policyholder Benefits Ceded: 1261000000.00
ACGLN income_statement (quarterly, 2025-03-31) — Policyholder Benefits Gross: 3848000000.00
ACGLN balance_sheet (quarterly, 2025-03-31) — Preferred Shares Number: 830000.00
ACGLN balance_sheet (quarterly, 2025-03-31) — Preferred Stock: 830000000.00
ACGLN cash_flow (quarterly, 2025-03-31) — Preferred Stock Dividend Paid: -10000000.00
ACGLN income_statement (quarterly, 2025-03-31) — Preferred Stock Dividends: 10000000.00
ACGLN balance_sheet (quarterly, 2025-03-31) — Preferred Stock Equity: 830000000.00
ACGLN balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 2895000000.00
ACGLN income_statement (quarterly, 2025-03-31) — Pretax Income: 678000000.00
ACGLN cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: -10923000000.00
ACGLN cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -9000000.00
ACGLN balance_sheet (quarterly, 2025-03-31) — Receivables: 17788000000.00
ACGLN income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 49000000.00
ACGLN cash_flow (quarterly, 2025-03-31) — Repurchase Of Capital Stock: -224000000.00
ACGLN balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 23250000000.00
ACGLN cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 9926000000.00
ACGLN balance_sheet (quarterly, 2025-03-31) — Share Issued: 597400000.00
ACGLN cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 74000000.00
ACGLN balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 21545000000.00
ACGLN balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 19407000000.00
ACGLN income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
ACGLN income_statement (quarterly, 2025-03-31) — Tax Provision: 121000000.00
ACGLN income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.18
ACGLN balance_sheet (quarterly, 2025-03-31) — Total Assets: 75176000000.00
ACGLN balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 24273000000.00
ACGLN balance_sheet (quarterly, 2025-03-31) — Total Debt: 2728000000.00
ACGLN balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 21545000000.00
ACGLN income_statement (quarterly, 2025-03-31) — Total Expenses: 3914000000.00
ACGLN balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 53631000000.00
ACGLN balance_sheet (quarterly, 2025-03-31) — Treasury Shares Number: 221800000.00
ACGLN balance_sheet (quarterly, 2025-03-31) — Treasury Stock: 4716000000.00
ACGLN income_statement (quarterly, 2025-06-30) — +Total Revenue: 4965000000.00
ACGLN balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 5127000000.00
ACGLN balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 18391000000.00
ACGLN balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 2660000000.00
ACGLN income_statement (quarterly, 2025-06-30) — Amortization: 48000000.00
ACGLN cash_flow (quarterly, 2025-06-30) — Amortization Cash Flow: 48000000.00
ACGLN cash_flow (quarterly, 2025-06-30) — Amortization Of Intangibles: 48000000.00
ACGLN cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 1985000000.00
ACGLN cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -12000000.00
ACGLN balance_sheet (quarterly, 2025-06-30) — Capital Stock: 831000000.00
ACGLN balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 983000000.00
ACGLN balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 10313000000.00
ACGLN cash_flow (quarterly, 2025-06-30) — Cash Dividends Paid: -12000000.00
ACGLN cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -128000000.00
ACGLN cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -1228000000.00
ACGLN cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 1124000000.00
ACGLN cash_flow (quarterly, 2025-06-30) — Change In Account Payable: 159000000.00
ACGLN cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: -277000000.00
ACGLN cash_flow (quarterly, 2025-06-30) — Change In Payable: 159000000.00
ACGLN cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 159000000.00
ACGLN cash_flow (quarterly, 2025-06-30) — Change In Receivables: -352000000.00
ACGLN cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 134000000.00
ACGLN cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: -352000000.00
ACGLN cash_flow (quarterly, 2025-06-30) — Changes In Cash: -232000000.00
ACGLN balance_sheet (quarterly, 2025-06-30) — Common Stock: 1000000.00
ACGLN cash_flow (quarterly, 2025-06-30) — Common Stock Dividend Paid: -2000000.00
ACGLN balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 22211000000.00
ACGLN cash_flow (quarterly, 2025-06-30) — Common Stock Payments: -135000000.00
ACGLN cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 48000000.00
ACGLN income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 48000000.00
ACGLN income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 1227000000.00
ACGLN income_statement (quarterly, 2025-06-30) — EBIT: 1449000000.00
ACGLN income_statement (quarterly, 2025-06-30) — Earnings From Equity Interest Net Of Tax: 40000000.00
ACGLN cash_flow (quarterly, 2025-06-30) — Earnings Losses From Equity Investments: -95000000.00
ACGLN cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: 55000000.00
ACGLN cash_flow (quarterly, 2025-06-30) — End Cash Position: 1808000000.00
ACGLN cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -128000000.00
ACGLN cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 1112000000.00
ACGLN cash_flow (quarterly, 2025-06-30) — Gain Loss On Investment Securities: -225000000.00
ACGLN balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: -48000000.00
ACGLN balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 1319000000.00
ACGLN cash_flow (quarterly, 2025-06-30) — Income Tax Paid Supplemental Data: 131000000.00
ACGLN income_statement (quarterly, 2025-06-30) — Interest Expense: 38000000.00
ACGLN income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 38000000.00
ACGLN cash_flow (quarterly, 2025-06-30) — Interest Paid Supplemental Data: 64000000.00
ACGLN balance_sheet (quarterly, 2025-06-30) — Invested Capital: 24939000000.00
ACGLN cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -1228000000.00
ACGLN balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 43839000000.00
ACGLN balance_sheet (quarterly, 2025-06-30) — Investments In Other Ventures Under Equity Method: 7922000000.00
ACGLN balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 2728000000.00
ACGLN balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 2728000000.00
ACGLN balance_sheet (quarterly, 2025-06-30) — Long Term Equity Investment: 7922000000.00
ACGLN income_statement (quarterly, 2025-06-30) — Loss Adjustment Expense: 2303000000.00
ACGLN cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: -116000000.00
ACGLN balance_sheet (quarterly, 2025-06-30) — Net Debt: 1745000000.00
ACGLN income_statement (quarterly, 2025-06-30) — Net Income: 1237000000.00
ACGLN income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 1227000000.00
ACGLN income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 1237000000.00
ACGLN income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 1237000000.00
ACGLN income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 1237000000.00
ACGLN cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 1237000000.00
ACGLN income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 1237000000.00
ACGLN income_statement (quarterly, 2025-06-30) — Net Interest Income: -38000000.00
ACGLN cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: -1215000000.00
ACGLN income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -38000000.00
ACGLN cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: 0.00
ACGLN cash_flow (quarterly, 2025-06-30) — Net Other Investing Changes: -1000000.00
ACGLN cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -12000000.00
ACGLN income_statement (quarterly, 2025-06-30) — Net Policyholder Benefits And Claims: 2303000000.00
ACGLN balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 21722000000.00
ACGLN income_statement (quarterly, 2025-06-30) — Normalized Income: 1237000000.00
ACGLN cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 1124000000.00
ACGLN cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: -320000000.00
ACGLN income_statement (quarterly, 2025-06-30) — Operating Revenue: 4965000000.00
ACGLN balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 375400000.00
ACGLN balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: -48000000.00
ACGLN income_statement (quarterly, 2025-06-30) — Other Income Expense: 80000000.00
ACGLN income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 503000000.00
ACGLN balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 9330000000.00
ACGLN balance_sheet (quarterly, 2025-06-30) — Payables: 5127000000.00
ACGLN balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 5127000000.00
ACGLN income_statement (quarterly, 2025-06-30) — Policyholder Benefits Ceded: 785000000.00
ACGLN income_statement (quarterly, 2025-06-30) — Policyholder Benefits Gross: 3088000000.00
ACGLN balance_sheet (quarterly, 2025-06-30) — Preferred Shares Number: 830000.00
ACGLN balance_sheet (quarterly, 2025-06-30) — Preferred Stock: 830000000.00
ACGLN cash_flow (quarterly, 2025-06-30) — Preferred Stock Dividend Paid: -10000000.00
ACGLN income_statement (quarterly, 2025-06-30) — Preferred Stock Dividends: 10000000.00
ACGLN balance_sheet (quarterly, 2025-06-30) — Preferred Stock Equity: 830000000.00
ACGLN balance_sheet (quarterly, 2025-06-30) — Prepaid Assets: 3229000000.00
ACGLN income_statement (quarterly, 2025-06-30) — Pretax Income: 1411000000.00
ACGLN cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: -8864000000.00
ACGLN cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -12000000.00
ACGLN balance_sheet (quarterly, 2025-06-30) — Receivables: 18391000000.00
ACGLN income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 48000000.00
ACGLN cash_flow (quarterly, 2025-06-30) — Repurchase Of Capital Stock: -135000000.00
ACGLN balance_sheet (quarterly, 2025-06-30) — Retained Earnings: 24477000000.00
ACGLN cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 7649000000.00
ACGLN balance_sheet (quarterly, 2025-06-30) — Share Issued: 599100000.00
ACGLN cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 25000000.00
ACGLN balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 23041000000.00
ACGLN balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 20892000000.00
ACGLN income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
ACGLN income_statement (quarterly, 2025-06-30) — Tax Provision: 214000000.00
ACGLN income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.15
ACGLN balance_sheet (quarterly, 2025-06-30) — Total Assets: 78788000000.00
ACGLN balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 25769000000.00
ACGLN balance_sheet (quarterly, 2025-06-30) — Total Debt: 2728000000.00
ACGLN balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 23041000000.00
ACGLN income_statement (quarterly, 2025-06-30) — Total Expenses: 3554000000.00
ACGLN balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 55747000000.00
ACGLN balance_sheet (quarterly, 2025-06-30) — Treasury Shares Number: 223700000.00
ACGLN balance_sheet (quarterly, 2025-06-30) — Treasury Stock: 4879000000.00
ACGLN income_statement (quarterly, 2025-09-30) — +Total Revenue: 4977000000.00
ACGLN balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 4931000000.00
ACGLN balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 17807000000.00
ACGLN balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 2682000000.00
ACGLN income_statement (quarterly, 2025-09-30) — Amortization: 49000000.00
ACGLN cash_flow (quarterly, 2025-09-30) — Amortization Cash Flow: 49000000.00
ACGLN cash_flow (quarterly, 2025-09-30) — Amortization Of Intangibles: 49000000.00
ACGLN cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 1808000000.00
ACGLN cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -12000000.00
ACGLN balance_sheet (quarterly, 2025-09-30) — Capital Stock: 831000000.00
ACGLN balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 1063000000.00
ACGLN balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 11166000000.00
ACGLN cash_flow (quarterly, 2025-09-30) — Cash Dividends Paid: -10000000.00
ACGLN cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -743000000.00
ACGLN cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -1383000000.00
ACGLN cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 2186000000.00
ACGLN cash_flow (quarterly, 2025-09-30) — Change In Account Payable: -207000000.00
ACGLN cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: 401000000.00
ACGLN cash_flow (quarterly, 2025-09-30) — Change In Payable: -207000000.00
ACGLN cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: -207000000.00
ACGLN cash_flow (quarterly, 2025-09-30) — Change In Receivables: 601000000.00
ACGLN cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 1122000000.00
ACGLN cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: 601000000.00
ACGLN cash_flow (quarterly, 2025-09-30) — Changes In Cash: 60000000.00
ACGLN balance_sheet (quarterly, 2025-09-30) — Common Stock: 1000000.00
ACGLN cash_flow (quarterly, 2025-09-30) — Common Stock Dividend Paid: 0.00
ACGLN balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 22889000000.00
ACGLN cash_flow (quarterly, 2025-09-30) — Common Stock Issuance: 1000000.00
ACGLN cash_flow (quarterly, 2025-09-30) — Common Stock Payments: -732000000.00
ACGLN cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 49000000.00
ACGLN income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 49000000.00
ACGLN income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 1340000000.00
ACGLN income_statement (quarterly, 2025-09-30) — EBIT: 1540000000.00
ACGLN income_statement (quarterly, 2025-09-30) — Earnings From Equity Interest Net Of Tax: 62000000.00
ACGLN cash_flow (quarterly, 2025-09-30) — Earnings Losses From Equity Investments: -158000000.00
ACGLN cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: -14000000.00
ACGLN cash_flow (quarterly, 2025-09-30) — End Cash Position: 1854000000.00
ACGLN cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -743000000.00
ACGLN cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 2174000000.00
ACGLN cash_flow (quarterly, 2025-09-30) — Gain Loss On Investment Securities: -202000000.00
ACGLN balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: 0.00
ACGLN balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 1268000000.00
ACGLN cash_flow (quarterly, 2025-09-30) — Income Tax Paid Supplemental Data: 166000000.00
ACGLN income_statement (quarterly, 2025-09-30) — Interest Expense: 37000000.00
ACGLN income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 37000000.00
ACGLN income_statement (quarterly, 2025-09-30) — Interest Income: 10000000.00
ACGLN cash_flow (quarterly, 2025-09-30) — Interest Paid Supplemental Data: 0.00
ACGLN balance_sheet (quarterly, 2025-09-30) — Invested Capital: 25617000000.00
ACGLN cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -1383000000.00
ACGLN balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 44829000000.00
ACGLN balance_sheet (quarterly, 2025-09-30) — Investments In Other Ventures Under Equity Method: 7649000000.00
ACGLN cash_flow (quarterly, 2025-09-30) — Issuance Of Capital Stock: 1000000.00
ACGLN balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 2728000000.00
ACGLN balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 2728000000.00
ACGLN balance_sheet (quarterly, 2025-09-30) — Long Term Equity Investment: 7649000000.00
ACGLN income_statement (quarterly, 2025-09-30) — Loss Adjustment Expense: 2200000000.00
ACGLN cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: -731000000.00
ACGLN balance_sheet (quarterly, 2025-09-30) — Net Debt: 1665000000.00
ACGLN income_statement (quarterly, 2025-09-30) — Net Income: 1350000000.00
ACGLN income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 1340000000.00
ACGLN income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 1350000000.00
ACGLN income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 1350000000.00
ACGLN income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 1350000000.00
ACGLN cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 1350000000.00
ACGLN income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 1350000000.00
ACGLN income_statement (quarterly, 2025-09-30) — Net Interest Income: -37000000.00
ACGLN cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: -1369000000.00
ACGLN income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -37000000.00
ACGLN cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: -2000000.00
ACGLN cash_flow (quarterly, 2025-09-30) — Net Other Investing Changes: -2000000.00
ACGLN cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -12000000.00
ACGLN income_statement (quarterly, 2025-09-30) — Net Policyholder Benefits And Claims: 2200000000.00
ACGLN balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 22451000000.00
ACGLN income_statement (quarterly, 2025-09-30) — Normalized Income: 1350000000.00
ACGLN cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 2186000000.00
ACGLN cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: -360000000.00
ACGLN income_statement (quarterly, 2025-09-30) — Operating Revenue: 4977000000.00
ACGLN balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 367300000.00
ACGLN income_statement (quarterly, 2025-09-30) — Other Income Expense: 72000000.00
ACGLN income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 536000000.00
ACGLN balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 10103000000.00
ACGLN balance_sheet (quarterly, 2025-09-30) — Payables: 4931000000.00
ACGLN balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 4931000000.00
ACGLN income_statement (quarterly, 2025-09-30) — Policyholder Benefits Ceded: 780000000.00
ACGLN income_statement (quarterly, 2025-09-30) — Policyholder Benefits Gross: 2980000000.00
ACGLN balance_sheet (quarterly, 2025-09-30) — Preferred Shares Number: 830000.00
ACGLN balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 830000000.00
ACGLN cash_flow (quarterly, 2025-09-30) — Preferred Stock Dividend Paid: -10000000.00
ACGLN income_statement (quarterly, 2025-09-30) — Preferred Stock Dividends: 10000000.00
ACGLN balance_sheet (quarterly, 2025-09-30) — Preferred Stock Equity: 830000000.00
ACGLN balance_sheet (quarterly, 2025-09-30) — Prepaid Assets: 3079000000.00
ACGLN income_statement (quarterly, 2025-09-30) — Pretax Income: 1503000000.00
ACGLN cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: -11409000000.00
ACGLN cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -12000000.00
ACGLN balance_sheet (quarterly, 2025-09-30) — Receivables: 17807000000.00
ACGLN income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 49000000.00
ACGLN cash_flow (quarterly, 2025-09-30) — Repurchase Of Capital Stock: -732000000.00
ACGLN balance_sheet (quarterly, 2025-09-30) — Retained Earnings: 25817000000.00
ACGLN cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 10040000000.00
ACGLN balance_sheet (quarterly, 2025-09-30) — Share Issued: 599200000.00
ACGLN cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 25000000.00
ACGLN balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 23719000000.00
ACGLN balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 21621000000.00
ACGLN income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
ACGLN income_statement (quarterly, 2025-09-30) — Tax Provision: 215000000.00
ACGLN income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.14
ACGLN balance_sheet (quarterly, 2025-09-30) — Total Assets: 79185000000.00
ACGLN balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 26447000000.00
ACGLN balance_sheet (quarterly, 2025-09-30) — Total Debt: 2728000000.00
ACGLN balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 23719000000.00
ACGLN income_statement (quarterly, 2025-09-30) — Total Expenses: 3474000000.00
ACGLN balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 55466000000.00
ACGLN balance_sheet (quarterly, 2025-09-30) — Treasury Shares Number: 231900000.00
ACGLN balance_sheet (quarterly, 2025-09-30) — Treasury Stock: 5611000000.00
ACGLN income_statement (annual, 2025-12-31) — +Total Revenue: 19294000000.00
ACGLN income_statement (quarterly, 2025-12-31) — +Total Revenue: 4760000000.00
ACGLN balance_sheet (annual, 2025-12-31) — Accounts Payable: 4597000000.00
ACGLN balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 4597000000.00
ACGLN balance_sheet (annual, 2025-12-31) — Accounts Receivable: 17519000000.00
ACGLN balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 17519000000.00
ACGLN balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 2735000000.00
ACGLN balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 2735000000.00
ACGLN income_statement (annual, 2025-12-31) — Amortization: 193000000.00
ACGLN income_statement (quarterly, 2025-12-31) — Amortization: 47000000.00
ACGLN cash_flow (annual, 2025-12-31) — Amortization Cash Flow: 193000000.00
ACGLN cash_flow (quarterly, 2025-12-31) — Amortization Cash Flow: 47000000.00
ACGLN cash_flow (annual, 2025-12-31) — Amortization Of Intangibles: 193000000.00
ACGLN cash_flow (quarterly, 2025-12-31) — Amortization Of Intangibles: 47000000.00
ACGLN cash_flow (annual, 2025-12-31) — Beginning Cash Position: 1760000000.00
ACGLN cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 1854000000.00
ACGLN cash_flow (annual, 2025-12-31) — Capital Expenditure: -44000000.00
ACGLN cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -11000000.00
ACGLN balance_sheet (annual, 2025-12-31) — Capital Stock: 831000000.00
ACGLN balance_sheet (quarterly, 2025-12-31) — Capital Stock: 831000000.00
ACGLN balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 993000000.00
ACGLN balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 993000000.00
ACGLN balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 11543000000.00
ACGLN balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 11543000000.00
ACGLN cash_flow (annual, 2025-12-31) — Cash Dividends Paid: -47000000.00
ACGLN cash_flow (quarterly, 2025-12-31) — Cash Dividends Paid: -10000000.00
ACGLN cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -1890000000.00
ACGLN cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -778000000.00
ACGLN cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -4036000000.00
ACGLN cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -417000000.00
ACGLN cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 6172000000.00
ACGLN cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 1404000000.00
ACGLN cash_flow (annual, 2025-12-31) — Change In Account Payable: 137000000.00
ACGLN cash_flow (quarterly, 2025-12-31) — Change In Account Payable: -319000000.00
ACGLN cash_flow (annual, 2025-12-31) — Change In Other Working Capital: 309000000.00
ACGLN cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: 107000000.00
ACGLN cash_flow (annual, 2025-12-31) — Change In Payable: 137000000.00
ACGLN cash_flow (quarterly, 2025-12-31) — Change In Payable: -319000000.00
ACGLN cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 137000000.00
ACGLN cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: -319000000.00
ACGLN cash_flow (annual, 2025-12-31) — Change In Receivables: 38000000.00
ACGLN cash_flow (quarterly, 2025-12-31) — Change In Receivables: 731000000.00
ACGLN cash_flow (annual, 2025-12-31) — Change In Working Capital: 2331000000.00
ACGLN cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 296000000.00
ACGLN cash_flow (annual, 2025-12-31) — Changes In Account Receivables: 38000000.00
ACGLN cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: 731000000.00
ACGLN cash_flow (annual, 2025-12-31) — Changes In Cash: 246000000.00
ACGLN cash_flow (quarterly, 2025-12-31) — Changes In Cash: 209000000.00
ACGLN balance_sheet (annual, 2025-12-31) — Common Stock: 1000000.00
ACGLN balance_sheet (quarterly, 2025-12-31) — Common Stock: 1000000.00
ACGLN cash_flow (annual, 2025-12-31) — Common Stock Dividend Paid: -7000000.00
ACGLN cash_flow (quarterly, 2025-12-31) — Common Stock Dividend Paid: 0.00
ACGLN balance_sheet (annual, 2025-12-31) — Common Stock Equity: 23376000000.00
ACGLN balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 23376000000.00
ACGLN cash_flow (annual, 2025-12-31) — Common Stock Issuance: 50000000.00
ACGLN cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: 30000000.00
ACGLN cash_flow (annual, 2025-12-31) — Common Stock Payments: -1889000000.00
ACGLN cash_flow (quarterly, 2025-12-31) — Common Stock Payments: -798000000.00
ACGLN cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 193000000.00
ACGLN cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 47000000.00
ACGLN income_statement (annual, 2025-12-31) — Depreciation And Amortization In Income Statement: 193000000.00
ACGLN income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 47000000.00
ACGLN income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 4359000000.00
ACGLN income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 1228000000.00
ACGLN income_statement (annual, 2025-12-31) — EBIT: 5127000000.00
ACGLN income_statement (quarterly, 2025-12-31) — EBIT: 1425000000.00
ACGLN income_statement (annual, 2025-12-31) — Earnings From Equity Interest Net Of Tax: 180000000.00
ACGLN income_statement (quarterly, 2025-12-31) — Earnings From Equity Interest Net Of Tax: 61000000.00
ACGLN cash_flow (annual, 2025-12-31) — Earnings Losses From Equity Investments: -459000000.00
ACGLN cash_flow (quarterly, 2025-12-31) — Earnings Losses From Equity Investments: -194000000.00
ACGLN cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: 61000000.00
ACGLN cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: 4000000.00
ACGLN cash_flow (annual, 2025-12-31) — End Cash Position: 2067000000.00
ACGLN cash_flow (quarterly, 2025-12-31) — End Cash Position: 2067000000.00
ACGLN cash_flow (annual, 2025-12-31) — Financing Cash Flow: -1890000000.00
ACGLN cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -778000000.00
ACGLN cash_flow (annual, 2025-12-31) — Free Cash Flow: 6128000000.00
ACGLN cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 1393000000.00
ACGLN cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: -440000000.00
ACGLN cash_flow (quarterly, 2025-12-31) — Gain Loss On Investment Securities: -7000000.00
ACGLN balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 5000000.00
ACGLN balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 5000000.00
ACGLN balance_sheet (annual, 2025-12-31) — Goodwill: 607000000.00
ACGLN balance_sheet (quarterly, 2025-12-31) — Goodwill: 607000000.00
ACGLN balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 1222000000.00
ACGLN balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 1222000000.00
ACGLN cash_flow (annual, 2025-12-31) — Income Tax Paid Supplemental Data: 458000000.00
ACGLN cash_flow (quarterly, 2025-12-31) — Income Tax Paid Supplemental Data: 143000000.00
ACGLN income_statement (annual, 2025-12-31) — Interest Expense: 148000000.00
ACGLN income_statement (quarterly, 2025-12-31) — Interest Expense: 38000000.00
ACGLN income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 148000000.00
ACGLN income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 38000000.00
ACGLN cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 127000000.00
ACGLN cash_flow (quarterly, 2025-12-31) — Interest Paid Supplemental Data: 63000000.00
ACGLN balance_sheet (annual, 2025-12-31) — Invested Capital: 26105000000.00
ACGLN balance_sheet (quarterly, 2025-12-31) — Invested Capital: 26105000000.00
ACGLN cash_flow (annual, 2025-12-31) — Investing Cash Flow: -4036000000.00
ACGLN cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -417000000.00
ACGLN balance_sheet (annual, 2025-12-31) — Investments And Advances: 45860000000.00
ACGLN balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 45860000000.00
ACGLN balance_sheet (annual, 2025-12-31) — Investments In Other Ventures Under Equity Method: 7766000000.00
ACGLN balance_sheet (quarterly, 2025-12-31) — Investments In Other Ventures Under Equity Method: 7766000000.00
ACGLN cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 50000000.00
ACGLN cash_flow (quarterly, 2025-12-31) — Issuance Of Capital Stock: 30000000.00
ACGLN balance_sheet (annual, 2025-12-31) — Long Term Debt: 2729000000.00
ACGLN balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 2729000000.00
ACGLN balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 2729000000.00
ACGLN balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 2729000000.00
ACGLN balance_sheet (annual, 2025-12-31) — Long Term Equity Investment: 7766000000.00
ACGLN balance_sheet (quarterly, 2025-12-31) — Long Term Equity Investment: 7766000000.00
ACGLN income_statement (annual, 2025-12-31) — Loss Adjustment Expense: 9370000000.00
ACGLN income_statement (quarterly, 2025-12-31) — Loss Adjustment Expense: 2280000000.00
ACGLN income_statement (annual, 2025-12-31) — Minority Interests: 0.00
ACGLN cash_flow (annual, 2025-12-31) — Net Business Purchase And Sale: 0.00
ACGLN cash_flow (quarterly, 2025-12-31) — Net Business Purchase And Sale: 0.00
ACGLN cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: -1839000000.00
ACGLN cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: -768000000.00
ACGLN balance_sheet (annual, 2025-12-31) — Net Debt: 1736000000.00
ACGLN balance_sheet (quarterly, 2025-12-31) — Net Debt: 1736000000.00
ACGLN income_statement (annual, 2025-12-31) — Net Income: 4399000000.00
ACGLN income_statement (quarterly, 2025-12-31) — Net Income: 1238000000.00
ACGLN income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 4359000000.00
ACGLN income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 1228000000.00
ACGLN income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 4399000000.00
ACGLN income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 1238000000.00
ACGLN income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 4399000000.00
ACGLN income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 1238000000.00
ACGLN income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 4399000000.00
ACGLN income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 1238000000.00
ACGLN cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 4399000000.00
ACGLN cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 1238000000.00
ACGLN income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 4399000000.00
ACGLN income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 1238000000.00
ACGLN income_statement (annual, 2025-12-31) — Net Interest Income: -148000000.00
ACGLN income_statement (quarterly, 2025-12-31) — Net Interest Income: -38000000.00
ACGLN cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: -4098000000.00
ACGLN cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: -517000000.00
ACGLN income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -148000000.00
ACGLN income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -38000000.00
ACGLN cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -4000000.00
ACGLN cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: 0.00
ACGLN cash_flow (annual, 2025-12-31) — Net Other Investing Changes: 106000000.00
ACGLN cash_flow (quarterly, 2025-12-31) — Net Other Investing Changes: 111000000.00
ACGLN cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -44000000.00
ACGLN cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -11000000.00
ACGLN income_statement (annual, 2025-12-31) — Net Policyholder Benefits And Claims: 9370000000.00
ACGLN income_statement (quarterly, 2025-12-31) — Net Policyholder Benefits And Claims: 2280000000.00
ACGLN balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 22984000000.00
ACGLN balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 22984000000.00
ACGLN income_statement (annual, 2025-12-31) — Normalized Income: 4399000000.00
ACGLN income_statement (quarterly, 2025-12-31) — Normalized Income: 1238000000.00
ACGLN cash_flow (annual, 2025-12-31) — Operating Cash Flow: 6172000000.00
ACGLN cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 1404000000.00
ACGLN cash_flow (annual, 2025-12-31) — Operating Gains Losses: -899000000.00
ACGLN cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: -201000000.00
ACGLN income_statement (annual, 2025-12-31) — Operating Revenue: 19294000000.00
ACGLN income_statement (quarterly, 2025-12-31) — Operating Revenue: 4760000000.00
ACGLN balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 359000000.00
ACGLN balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 359000000.00
ACGLN balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: 5000000.00
ACGLN balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: 5000000.00
ACGLN income_statement (annual, 2025-12-31) — Other Income Expense: 271000000.00
ACGLN income_statement (quarterly, 2025-12-31) — Other Income Expense: 68000000.00
ACGLN balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 615000000.00
ACGLN balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 615000000.00
ACGLN income_statement (annual, 2025-12-31) — Other Operating Expenses: 1955000000.00
ACGLN income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 384000000.00
ACGLN balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 10550000000.00
ACGLN balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 10550000000.00
ACGLN balance_sheet (annual, 2025-12-31) — Payables: 4597000000.00
ACGLN balance_sheet (quarterly, 2025-12-31) — Payables: 4597000000.00
ACGLN balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 4597000000.00
ACGLN balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 4597000000.00
ACGLN income_statement (annual, 2025-12-31) — Policyholder Benefits Ceded: 3865000000.00
ACGLN income_statement (quarterly, 2025-12-31) — Policyholder Benefits Ceded: 1039000000.00
ACGLN income_statement (annual, 2025-12-31) — Policyholder Benefits Gross: 13235000000.00
ACGLN income_statement (quarterly, 2025-12-31) — Policyholder Benefits Gross: 3319000000.00
ACGLN balance_sheet (annual, 2025-12-31) — Preferred Shares Number: 830000.00
ACGLN balance_sheet (quarterly, 2025-12-31) — Preferred Shares Number: 830000.00
ACGLN balance_sheet (annual, 2025-12-31) — Preferred Stock: 830000000.00
ACGLN balance_sheet (quarterly, 2025-12-31) — Preferred Stock: 830000000.00
ACGLN cash_flow (annual, 2025-12-31) — Preferred Stock Dividend Paid: -40000000.00
ACGLN cash_flow (quarterly, 2025-12-31) — Preferred Stock Dividend Paid: -10000000.00
ACGLN income_statement (annual, 2025-12-31) — Preferred Stock Dividends: 40000000.00
ACGLN income_statement (quarterly, 2025-12-31) — Preferred Stock Dividends: 10000000.00
ACGLN balance_sheet (annual, 2025-12-31) — Preferred Stock Equity: 830000000.00
ACGLN balance_sheet (quarterly, 2025-12-31) — Preferred Stock Equity: 830000000.00
ACGLN balance_sheet (annual, 2025-12-31) — Prepaid Assets: 2659000000.00
ACGLN balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 2659000000.00
ACGLN income_statement (annual, 2025-12-31) — Pretax Income: 4979000000.00
ACGLN income_statement (quarterly, 2025-12-31) — Pretax Income: 1387000000.00
ACGLN cash_flow (annual, 2025-12-31) — Purchase Of Investment: -40166000000.00